XML 73 R22.htm IDEA: XBRL DOCUMENT
v3.20.1

Investments in Affiliated Entities | 12 Months Ended
--- | ---
Dec. 31, 2019
Related Party Transactions [Abstract] |
Investments in Affiliated Entities | Investments in Affiliated Entities The Company held 1,644,155 common shares, representing a 7.5% and 7.8% ownership interest in GeneOne as of December 31, 2019 and 2018, respectively, and 395,758 common shares, representing a 15.0% and 15.1% ownership interest in PLS as of December 31, 2019 and 2018, respectively. Please see further information as discussed in Note 2 and Note 6.

X
- Definition The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SX 210.3A-04) -URI http://asc.fasb.org/extlink&oid=116822174&loc=d3e355119-122828 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -URI http://asc.fasb.org/topic&trid=2196965 + Details
Name: | us-gaap_EquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration